From a Barcelona library to YouTube: PHOTOTHERAPORT joins the European Researchers’ Night 2026

PHOTOTHERAPORT researchers took part in the 2026 edition of the European Researchers’ Night in Barcelona and San Fernando (Cádiz). In Barcelona, with two micro-talks organised by the Catalan Association for Science Communication (ACCC), Galyna Malieieva (IBEC) spoke about photoswitchable drugs at the Gabriel García Márquez library, while Cristina López Cabezón (IIBB-CSIC) shared her research through a video micro-talk available on the event’s YouTube channel. In Cádiz, Sonia Torres and Esther Berrocoso (University of Cádiz) brought the project’s pain research to a secondary school classroom and to the public at Plaza del Rey.

The European Researchers’ Night is a Europe-wide public event, funded by the European Commission through the Marie Skłodowska-Curie Actions (MSCA) under Horizon Europe, that brings researchers and citizens together. Held every year around the last Friday of September, it takes place simultaneously in hundreds of cities in more than 25 European countries and attracts over a million visitors. Through talks, workshops, experiments and games, its aim is to show how research impacts everyday life, celebrate scientific achievements and spark young people’s interest in research careers. In Catalonia, La Nit de la Recerca offered more than 250 activities across five territorial nodes; in the Barcelona–Vallès node, coordinated by ISGlobal, the Catalan Association for Science Communication (ACCC), the University of Barcelona and the Autonomous University of Barcelona, activities ran from 22 September to 2 October.

In Cádiz, the University of Cádiz (UCA) celebrated the 14th edition of the event, organised together with the San Fernando City Council and co-funded by the Spanish Foundation for Science and Technology (FECYT): its programme included around 70 outreach activities, five pre-events and 12 school visits, with more than 550 UCA researchers taking part and a main event held at Plaza del Rey in San Fernando on 25 September.

In-person micro-talk at the Gabriel García Márquez library

On Friday 2 October, Galyna Malieieva, researcher in the Nanoprobes and Nanoswitches group at IBEC, led by PHOTOTHERAPORT coordinator Pau Gorostiza, delivered the micro-talk “What are photoswitchable drugs and how can light help solve health problems?” to an audience of around 30 people at the Gabriel García Márquez library in Barcelona.

Malieieva invited the audience to imagine having “tiny light bulbs” inside the body that can be switched on from the outside. These light bulbs are, in fact, miniature light-emitting implants — light ports guided by nanocrystals — that convert invisible infrared light applied from outside the body into visible light. When placed exactly where a treatment is needed, they can illuminate a photoswitchable drug: a medicine synthesised in an inactive form that only becomes active when it is excited with a specific light. This combination allows the treatment to be activated only where and when it is needed, making it more controlled and localised, increasing its efficiency and reducing side effects.

The talk also explored how the “light-emitting implant – light-controlled drug” approach being developed within PHOTOTHERAPORT could open new possibilities for treating conditions of the nervous system, such as localised pain and epileptic seizures.

Video micro-talk on YouTube

PHOTOTHERAPORT was also present in the online programme of La Nit de la Recerca. Cristina López Cabezón, PhD student at Victoria Puig’s group at the Barcelona Institute for Biomedical Research (IIBB-CSIC), recorded a video micro-talk entitled “50 million reasons to research epilepsy”.

In the talk, López explains that epilepsy is a neurological disorder affecting more than 50 million people worldwide, in which seizures caused by abnormal electrical discharges in the brain can appear unpredictably. Beyond the seizures themselves, people with epilepsy often face significant social stigma. Although treatments exist, around one in three patients does not respond adequately to them, and many current drugs also affect normal brain function, causing important side effects.

To address this challenge, she presents the approach of PHOTOTHERAPORT: administering a drug that remains inactive until it is switched on by light, only in the brain region where seizures originate. This makes it possible to control exactly where, when and for how long the treatment acts. To deliver that light, the project is developing tiny, biocompatible implants that can be activated non-invasively from outside the body using infrared light, and that could be adapted to different types of epilepsy.

The ultimate goal, López concludes, is to achieve more precise, safer and personalised therapies, with fewer side effects and a better quality of life for patients — because behind the figures there are “50 million stories, 50 million reasons” to keep researching.

The video is available on La Nit de la Recerca YouTube channel. Watch it here: https://www.youtube.com/watch?v=l8yzR0dQ4Rc

Researchers in the classroom and “The Magic of the Brain” in San Fernando (Cádiz)

PHOTOTHERAPORT was also present at the European Researchers’ Night in Andalusia, where Sonia Torres and Esther Berrocoso, from the Neuropsychopharmacology and Psychobiology Research Group at the University of Cádiz (UCA), took part in two outreach activities.

On 23 September, Sonia Torres visited the IES Isla de León secondary school in San Fernando (Cádiz) as part of the “Researchers in the Classroom” programme, one of the 12 school activities proposed by UCA in this edition. Around 35 science-track secondary students and their teachers learned about the group’s lines of research in neuroscience, including the pain research carried out within PHOTOTHERAPORT. She also explained how to pursue a professional career in research and led a hands-on workshop on the histology of the central nervous system. On 25 September, Torres and Berrocoso joined UCA’s stand at Plaza del Rey in San Fernando with the workshop “The Magic of the Brain”, offering outreach activities adapted to all audiences. They explained that PHOTOTHERAPORT aims to develop luminescent implants and light-activated drugs for innovative neuromodulation therapies in the field of chronic pain and epilepsy. By using photopharmacology, they seek to inhibit the pain signal locally and on the patient’s demand, achieving a precise action of the drug while reducing its possible adverse effects. According to local media, the event at Plaza del Rey brought together more than 10,000 people.

Through talks, videos, school visits and hands-on workshops, PHOTOTHERAPORT researchers brought the science behind light-activated therapies closer to citizens. Taking research beyond the lab and into dialogue with society is part of the project’s commitment to open, accessible science.

more insights

Scroll to Top